Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig D Seaman

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 20, 2022
Von Willebrand Disease in Older Patients: A Retrospective Electronic Health Record ReviewCraig D Seaman
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 7, 2017
The Association of Aging With Von Willebrand Factor Levels and Bleeding Risk in Type 1 Von Willebrand DiseaseCraig D Seaman, Margaret V Ragni
Blood Advances|January 4, 2018
Sequential bypassing agents during major orthopedic surgery: a new approach to hemostasisCraig D Seaman, Margaret V Ragni
Thrombosis and Haemostasis|July 7, 2020
The Effect of Age on von Willebrand Factor and Bleeding Symptoms in von Willebrand DiseaseCraig D Seaman, Margaret V Ragni
Hematology/Oncology Clinics of North America|August 14, 2021
Hemophilia A (Factor VIII Deficiency)Craig D Seaman, Frederico Xavier, Margaret V Ragni
Thrombosis Research|October 22, 2013
Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: a U.S. perspectiveCraig D Seaman, Kenneth J Smith, Margaret V Ragni
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 3, 2021
Quality of periprocedural care in patients with von Willebrand diseaseCraig D Seaman, Marnie Bertolet, Jun Zhang, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 21, 2019
Emicizumab prophylaxis in patients with haemophilia A with and without inhibitorsPatrick T Ebbert, Frederico Xavier, Craig D Seaman, et al.
Pilot and Feasibility Studies|December 9, 2020
Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndromeCraig D Seaman, Enrico Novelli, Laura De Castro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 22, 2021
Factor VIII concentrate dosing with lean body mass, ideal body weight and total body weight in overweight and obesity: A randomized, controlled, open-label, 3 × 3 crossover trialCraig D Seaman, Jonathan G Yabes, Christina M Lalama, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 20, 2022
Von Willebrand Disease in Older Patients: A Retrospective Electronic Health Record ReviewCraig D Seaman
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 7, 2017
The Association of Aging With Von Willebrand Factor Levels and Bleeding Risk in Type 1 Von Willebrand DiseaseCraig D Seaman, Margaret V Ragni
Blood Advances|January 4, 2018
Sequential bypassing agents during major orthopedic surgery: a new approach to hemostasisCraig D Seaman, Margaret V Ragni
Thrombosis and Haemostasis|July 7, 2020
The Effect of Age on von Willebrand Factor and Bleeding Symptoms in von Willebrand DiseaseCraig D Seaman, Margaret V Ragni
Hematology/Oncology Clinics of North America|August 14, 2021
Hemophilia A (Factor VIII Deficiency)Craig D Seaman, Frederico Xavier, Margaret V Ragni
Thrombosis Research|October 22, 2013
Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: a U.S. perspectiveCraig D Seaman, Kenneth J Smith, Margaret V Ragni
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 3, 2021
Quality of periprocedural care in patients with von Willebrand diseaseCraig D Seaman, Marnie Bertolet, Jun Zhang, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 21, 2019
Emicizumab prophylaxis in patients with haemophilia A with and without inhibitorsPatrick T Ebbert, Frederico Xavier, Craig D Seaman, et al.
Pilot and Feasibility Studies|December 9, 2020
Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndromeCraig D Seaman, Enrico Novelli, Laura De Castro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 22, 2021
Factor VIII concentrate dosing with lean body mass, ideal body weight and total body weight in overweight and obesity: A randomized, controlled, open-label, 3 × 3 crossover trialCraig D Seaman, Jonathan G Yabes, Christina M Lalama, et al.
Pageof 2